One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.
MedPage Today on MSN
Two Types of ADT for Prostate Cancer, Different Effects on Coronary Artery Plaque
Significantly less progression, especially unstable lesions, with relugolix versus leuprol ...
ADT with leuprolide was tied to increased coronary plaque vs relugolix in prostate cancer. What does this mean for CV risk?
The REVELUTION (Relugolix versus Leuprolide Cardiac) trial compared coronary plaque after 2 types of androgen deprivation therapy (ADT) for prostate cancer.
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
Bayer's Nubeqa gains approval in India for non-chemotherapy treatment of advanced prostate cancer, enhancing patient care ...
MedPage Today on MSN
Paradigm Shift for Evaluating, Treating Biochemical Recurrence in Prostate Cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results